Moleculin Biotech Investor Presentation
Moleculin Biotech, Inc. has updated its corporate investor presentation and posted the deck to its website. The presentation, filed as Exhibit 99.1, provides a strategic and operational update on the company's clinical pipeline and corporate milestones.